CD1D and cancer: The importance of iNKT cells in the prevention of disease and as potential therapeutic targets was first recognized with observations that mice lacking CD1d or iNKT cells are predisposed to developing cancer, autoimmune and infectious disease [6], [51] and with the discovery of α-GalCer and its beneficial effects in murine models of disease [5], [18], [19], [20].